Nonadrenergic [3H]idazoxan binding sites are physically distinct from alpha 2-adrenergic receptors

MC Michel, JW Regan, MA Gerhardt, RR Neubig, PA Insel and HJ Motulsky

Department of Pharmacology, University of California San Diego, La Jolla.

We have recently demonstrated that the alpha 2-adrenergic radioligand [3H]idazoxan also labels additional sites that do not recognize catecholamines but bind with high affinity several chemically distinct drugs previously assumed to be highly selective for alpha 2-adrenergic receptors [Mol. Pharmacol. 35:324-330 (1989)]. We now have used three approaches to distinguish the nonadrenergic [3H]idazoxan sites from alpha 2-adrenergic receptors. (a) No nonadrenergic [3H]idazoxan binding sites were found in COS-7 cells transfected with the genes for the two known alpha 2-adrenergic receptor subtypes. (b) The ratio of alpha 2- adrenergic and nonadrenergic [3H]idazoxan sites in human platelet membranes varied considerably between various donors. (c) Highly purified platelet plasma membranes were enriched for alpha 2-adrenergic receptors but did not contain any nonadrenergic [3H]idazoxan binding sites. We conclude that the nonadrenergic [3H]idazoxan binding sites are not co-expressed with alpha 2-adrenergic receptors and at least in human platelets may be located in an intracellular compartment.

Volume 37, Issue 1, pp. 65-68, 01/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				F. Grossman, H. K. Manji, and W. Z. Potter Platelet {alpha}2-adrenoreceptors in depression: a critical examination J Psychopharmacol, January 1, 1993; 7(1_suppl): 4 - 18. [Abstract] [PDF]